Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/200907
Title: | Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? |
Author: | Cabrera Serrano, Antonio José Sánchez Maldonado, José Manuel Ter Horst, Rob Macauda, Angelica García Martín, Paloma Benavente, Yolanda Landi, Stefano Clay-Gilmour, Alyssa Niazi, Yasmeen Espinet, Blanca Rodríguez Sevilla, Juan José Pérez, Eva María Maffei, Rossana Blanco, Gonzalo Giaccherini, Matteo Cerhan, James R. Marasca, Roberto López Nevot, Miguel Ángel Chen Liang, Tzu Thomsen, Hauke Gámez, Irene Campa, Daniele Moreno Aguado, Víctor Sanjosé Llongueras, Silvia de Marcos Gragera, Rafael García Álvarez, María Dierssen Sotos, Trinidad Jerez, Andrés Butrym, Aleksandra Norman, Aaron D. Luppi, Mario Slager, Susan L. Hemminki, Kari Li, Yang Berndt, Sonja I. Casabonne, Delphine Alcoceba, Miguel Puiggros Metje, Anna M. Netea, Mihai G. Försti, Asta Canzian, Federico Sainz, Juan |
Keywords: | Leucèmia limfocítica crònica Genètica Chronic lymphocytic leukemia Genetics |
Issue Date: | 28-Apr-2023 |
Publisher: | MDPI AG |
Abstract: | Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/ijms24098005 |
It is part of: | International Journal of Molecular Sciences, 2023, vol. 24, num. 9 |
URI: | http://hdl.handle.net/2445/200907 |
Related resource: | https://doi.org/10.3390/ijms24098005 |
ISSN: | 1422-0067 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ijms-24-08005-v2.pdf | 771.03 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License